Literature DB >> 11900193

Precise modelling of the eye for proton therapy of intra-ocular tumours.

Barbara Dobler1, Rolf Bendl.   

Abstract

A new method is described that allows precise modelling of organs at risk and target volume for radiation therapy of intra-ocular tumours. The aim is to optimize the dose distribution and thus to reduce normal tissue complication probability. A geometrical 3D model based on elliptic shapes was developed that can be used for multimodal model-based segmentation of 3D patient data. The tumour volume cannot be clearly identified in CT and MR data, whereas the tumour outline can be discriminated very precisely in fundus photographs. Therefore, a multimodal 2D fundus diagram was developed, which allows us to correlate and display simultaneously information extracted from the eye model, 3D data and the fundus photograph. Thus, the connection of fundus diagram and 3D data is well-defined and the 3D volume can be calculated directly from the tumour outline drawn onto the fundus photograph and the tumour height measured by ultrasound. The method allows the calculation of a precise 3D eye model of the patient, including the different structures of the eye as well as the tumour volume. The method was developed as part of the new 3D treatment planning system OCTOPUS for proton therapy of ocular tumours within a national research project together with the Hahn-Meitner-Institut Berlin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900193     DOI: 10.1088/0031-9155/47/4/304

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  12 in total

1.  Assessment of targeting accuracy of a low-energy stereotactic radiosurgery treatment for age-related macular degeneration.

Authors:  Phillip J Taddei; Erik Chell; Steven Hansen; Michael Gertner; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.

Authors:  Aline I Riechardt; Bettina Karle; Dino Cordini; Jens Heufelder; Volker Budach; Antonia M Joussen; Johannes Gollrad
Journal:  Strahlenther Onkol       Date:  2017-06-19       Impact factor: 3.621

3.  Monte Carlo calculations and measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton therapy.

Authors:  Nicholas Koch; Wayne D Newhauser; Uwe Titt; Dan Gombos; Kevin Coombes; George Starkschall
Journal:  Phys Med Biol       Date:  2008-02-25       Impact factor: 3.609

4.  Efficient orbital structures segmentation with prior anatomical knowledge.

Authors:  Nava Aghdasi; Yangming Li; Angelique Berens; Richard A Harbison; Kris S Moe; Blake Hannaford
Journal:  J Med Imaging (Bellingham)       Date:  2017-07-22

5.  Quantification of radiation retinopathy after beam proton irradiation in centrally located choroidal melanoma.

Authors:  Catharina Busch; Julia Löwen; Daniel Pilger; Ira Seibel; Jens Heufelder; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-12       Impact factor: 3.117

Review 6.  Ocular Fluid Mechanics and Drug Delivery: A Review of Mathematical and Computational Models.

Authors:  Ajay Bhandari
Journal:  Pharm Res       Date:  2021-12-22       Impact factor: 4.200

7.  Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.

Authors:  Alexander Böker; Daniel Pilger; Dino Cordini; Ira Seibel; Aline I Riechardt; Antonia M Joussen; Nikolaos E Bechrakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-16       Impact factor: 3.117

8.  Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.

Authors:  Ira Seibel; Dino Cordini; Annette Hager; Johanna Tillner; Aline I Riechardt; Jens Heufelder; Anja M Davids; Matus Rehak; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-04       Impact factor: 3.117

9.  Multi-channel MRI segmentation of eye structures and tumors using patient-specific features.

Authors:  Carlos Ciller; Sandro De Zanet; Konstantinos Kamnitsas; Philippe Maeder; Ben Glocker; Francis L Munier; Daniel Rueckert; Jean-Philippe Thiran; Meritxell Bach Cuadra; Raphael Sznitman
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

10.  Breakdown of the blood-eye barrier in choroidal melanoma after proton beam radiotherapy.

Authors:  Annette Hager; Friederike Meissner; Aline-Isabel Riechardt; Theresa Bonaventura; Julia Löwen; Jens Heufelder; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.